6
Oct
2026
Troikaa Pharmaceuticals Ltd.
Exhibitor at CPHI Milan 2026 stand 16A26, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:India
-
On CPHI since:2022
-
Certificates:2
-
Employees:1000 - 4999
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 16A26, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Propofol MCT Injection & Propofol Injection
Strengths: 10 mg/ml (1% w/v) & 20 mg/ml (2% w/v)
Indication: For induction & maintenance of anesthesia Propofol MCT Injection: 10 mg/ml - Available as 20 ml Ampoule, 20 ml Vial, 50 ml Vial, 100 ml Vial & 20 mg/ml - Available as 20 ml Vial
Propofol Injection -&... -
Product Radio Contrast Injectables (Hanger Label)
Iohexol Injection 300 mg I/ml & 350 mg I/ml - Available as 50 ml and 100 ml Vial
Iopamidol Injection 300 mg I/ml, 370 mg I/ml - Available as 50 ml and 100 ml Vial
-
Product Midazolam Injection 5 mg/ml
Indication:
For preoperative sedation, conscious sedation prior to short diagnostic procedures, ICU sedation and induction of general anaesthesia prior to administration of other anaesthetic agents
Available as:
5 mg/ ml (3 ml & 10 ml ampoule) -
Product Levetiracetam Injection 100 mg/ml
Indication:
For treatment & control of seizures
Available as:
100 mg/ ml (5ml ampoule) -
Product Sevoflurane API, Propofol API, Desflurane API
High quality APIs, Minimum impurities offered by Troikaa Pharmachem Pvt. Ltd.; a wholly owned subsidiary of Troikaa Pharmeceuticals Ltd.
•Remifentanil Hydrochloride •Ketamine Hydrochloride
•Sevoflurane
•Desflurane
•Propofol
•Dexmedetomidine Hydroc...




